Abstract
ObjectivesTo evaluate the incidence of infection in patients with active rheumatoid arthritis (RA) treated with baricitinib, an oral selective Janus kinase (JAK)1 and JAK2 inhibitor.MethodsInfections are summarised from an integrated...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have